Development of TRPM8 antagonists to treat chronic pain and migraine

Pharmaceuticals

Volumn 10, Issue 2, 2017, Pages

  Weyer, Andy D ^a   Lehto, Sonya G ^b  

^a PACIFIC UNIVERSITY   (United States)

^b AMGEN INC   (United States)

Author keywords

Cold analgesia; Cold hyperalgesia; Mechanical hyperalgesia; Menthol; Migraine; Pain

Indexed keywords

ANALGESIC AGENT; ANTIMIGRAINE AGENT; TRANSIENT RECEPTOR POTENTIAL CHANNEL M8; TRANSIENT RECEPTOR POTENTIAL CHANNEL M8 ANTAGONIST; UNCLASSIFIED DRUG;

ALLODYNIA; ANALGESIA; CHRONIC PAIN; CYSTALGIA; DRUG EFFICACY; DRUG MECHANISM; DRUG SYNTHESIS; HUMAN; HYPERALGESIA; INFLAMMATORY PAIN; INTERSTITIAL CYSTITIS; MIGRAINE; NEUROMODULATION; NEUROPATHIC PAIN; NOCICEPTION; NONHUMAN; PROTEIN EXPRESSION; PROTEIN FUNCTION; REVIEW; TREATMENT RESPONSE; TRPM8 GENE;

EID: 85016992397     PISSN: None     EISSN: 14248247     Source Type: Journal    
DOI: 10.3390/ph10020037     Document Type: Review

References (76)

1. Peier, A.M.; Moqrich, A.; Hergarden, A.C.; Reeve, A.J.; Andersson, D.A.; Story, G.M.; Earley, T.J.; Dragoni, I.; McIntyre, P.; Bevan, S. et al. A TRP channel that senses cold stimuli and menthol. Cell 2002, 108, 705–715.[CrossRef]
2. McKemy, D.D.; Neuhausser, W.M.; Julius, D. Identification of a cold receptor reveals a general role for TRP channels in thermosensation. Nature 2002, 416, 52–58.[CrossRef] [PubMed]
3. Behrendt, H.J.; Germann, T.; Gillen, C.; Hatt, H.; Jostock, R.: Characterization of the mouse cold-menthol receptor TRPM8 and vanilloid receptor type-1 VR1 using a fluorometric imaging plate reader (FLIPR) assay. Br. J. Pharmacol. 2004, 141, 737–745.[CrossRef] [PubMed]
4. Dai, Y. TRPs and pain. Semin. Immunopathol. 2016, 38, 277–291.[CrossRef] [PubMed]
5. Eccles, R.: Menthol and related cooling compounds. J. Pharm. Pharmacol. 1994, 46, 618–630.[CrossRef] [PubMed]
6. Karashima, Y.; Damann, N.; Prenen, J.; Talavera, K.; Segal, A.; Voets, T.; Nilius, B. Bimodal action of menthol on the transient receptor potential channel TRPA1. J. Neurosci. 2007, 27, 9874–9884.[CrossRef] [PubMed]
7. Pan, R.; Tian, Y.; Gao, R.; Li, H.; Zhao, X.; Barrett, J.E.; Hu, H. Central mechanisms of menthol-induced analgesia. J. Pharm. Exp. Ther. 2012, 343, 661–672.[CrossRef] [PubMed]
8. Liu, B.; Fan, L.; Balakrishna, S.; Sui, A.; Morris, J.B.; Jordt, S.E. TRPM8 is the principal mediator of menthol-induced analgesia of acute and inflammatory pain. Pain 2013, 154, 2169–2177.[CrossRef] [PubMed]
9. Alpizar, Y.A.; Boonen, B.; Gees, M.; Sanchez, A.; Nilius, B.; Voets, T.; Talavera, K. Allyl isothiocyanate sensitizes TRPV1 to heat stimulation. Pflugers Arch. EJP 2014, 466, 507–515.[CrossRef] [PubMed]
10. Premkumar, L.S.; Raisinghani, M.; Pingle, S.C.; Long, C.; Pimentel, F. Downregulation of transient receptor potential melastatin 8 by protein kinase C-mediated dephosphorylation. J. Neurosci. 2005, 25, 11322–11329.[CrossRef] [PubMed]
11. Ramachandran, R.; Hyun, E.; Zhao, L.; Lapointe, T.K.; Chapman, K.; Hirota, C.L.; Ghosh, S.; McKemy, D.D.; Vergnolle, N.; Beck, P.L. et al. TRPM8 activation attenuates inflammatory responses in mouse models of colitis. Proc. Natl. Acad. Sci. USA 2013, 110, 7476–7481.[CrossRef] [PubMed]
12. Andersson, D.A.; Chase, H.W.; Bevan, S.: TRPM8 activation by menthol, icilin, and cold is differentially modulated by intracellular pH. J. Neurosci. 2004, 24, 5364–5369.[CrossRef] [PubMed]
13. Proudfoot, C.J.; Garry, E.M.; Cottrell, D.F.; Rosie, R.; Anderson, H.; Robertson, D.C.; Fleetwood-Walker, S.M.; Mitchell, R. Analgesia mediated by the TRPM8 cold receptor in chronic neuropathic pain. Curr. Boil. 2006, 16, 1591–1605.[CrossRef] [PubMed]
14. Su, L.; Wang, C.; Yu, Y.-H.; Ren, Y.-Y.; Xie, K.-L.; Wang, G.-L. Role of TRPM8 in dorsal root ganglion in nerve injury-induced chronic pain. BMC Neurosci. 2011, 12, 120.[CrossRef] [PubMed]
15. Knowlton, W.M.; Palkar, R.; Lippoldt, E.K.; McCoy, D.D.; Baluch, F.; Chen, J.; McKemy, D.D. A sensory-labeled line for cold: TRPM8-expressing sensory neurons define the cellular basis for cold, cold pain, and cooling-mediated analgesia. J. Neurosci. 2013, 33, 2837–2848.[CrossRef] [PubMed]
16. Dhaka, A.; Murray, A.N.; Mathur, J.; Earley, T.J.; Petrus, M.J.; Patapoutian, A. TRPM8 is required for cold sensation in mice. Neuron 2007, 54, 371–378.[CrossRef] [PubMed]
17. Andersen, H.H.; Gazerani, P.; Arendt-Nielsen, L.: High-Concentration L-Menthol Exhibits Counter-Irritancy to Neurogenic Inflammation, Thermal and Mechanical Hyperalgesia Caused by Trans-cinnamaldehyde. J. Pain 2016, 17, 919–929.[CrossRef] [PubMed]
18. Colvin, L.A.; Johnson, P.R.; Mitchell, R.; Fleetwood-Walker, S.M.; Fallon, M. From bench to bedside: A case of rapid reversal of bortezomib-induced neuropathic pain by the TRPM8 activator, menthol. J. Clin. Oncol. 2008, 26, 4519–4520.[CrossRef] [PubMed]
19. Davies, S.J.; Harding, L.M.; Baranowski, A.P. A novel treatment of postherpetic neuralgia using peppermint oil. Clin. J. Pain 2002, 18, 200–202.[CrossRef] [PubMed]
20. Willis, D.N.; Liu, B.; Ha, M.A.; Jordt, S.E.; Morris, J.B. Menthol attenuates respiratory irritation responses to multiple cigarette smoke irritants. FASEB J. 2011, 25, 4434–4444.[CrossRef] [PubMed]
21. Eberle, T.; Doganci, B.; Kramer, H.H.; Geber, C.; Fechir, M.; Magerl, W.; Birklein, F. Warm and cold complex regional pain syndromes: Differences beyond skin temperature? Neurology 2009, 72, 505–512.[CrossRef] [PubMed]
22. Maier, C.; Baron, R.; Tolle, T.R.; Binder, A.; Birbaumer, N.; Birklein, F.; Gierthmuhlen, J.; Flor, H.; Geber, C.; Huge, V. et al. Quantitative sensory testing in the German Research Network on Neuropathic Pain (DFNS): Somatosensory abnormalities in 1236 patients with different neuropathic pain syndromes. Pain 2010, 150, 439–450.[CrossRef] [PubMed]
23. Attal, N.; Bouhassira, D.; Gautron, M.; Vaillant, J.N.; Mitry, E.; Lepere, C.; Rougier, P.; Guirimand, F. Thermal hyperalgesia as a marker of oxaliplatin neurotoxicity: A prospective quantified sensory assessment study. Pain 2009, 144, 245–252.[CrossRef] [PubMed]
24. Binder, A.; Stengel, M.; Maag, R.; Wasner, G.; Schoch, R.; Moosig, F.; Schommer, B.; Baron, R.: Pain in oxaliplatin-induced neuropathy—sensitisation in the peripheral and central nociceptive system. Eur. J. Cancer 2007, 43, 2658–2663.[CrossRef] [PubMed]
25. Descoeur, J.; Pereira, V.; Pizzoccaro, A.; Francois, A.; Ling, B.; Maffre, V.; Couette, B.; Busserolles, J.; Courteix, C.; Noel, J. et al. Oxaliplatin-induced cold hypersensitivity is due to remodelling of ion channel expression in nociceptors. EMBO Mol. Med. 2011, 3, 266–278.[CrossRef] [PubMed]
26. Knowlton, W.M.; Daniels, R.L.; Palkar, R.; McCoy, D.D.; McKemy, D.D. Pharmacological blockade of TRPM8 ion channels alters cold and cold pain responses in mice. PLoS ONE 2011, 6, e25894.[CrossRef] [PubMed]
27. Gauchan, P.; Andoh, T.; Kato, A.; Kuraishi, Y. Involvement of increased expression of transient receptor potential melastatin 8 in oxaliplatin-induced cold allodynia in mice. Neurosci. Lett. 2009, 458, 93–95.[CrossRef] [PubMed]
28. Xing, H.; Chen, M.; Ling, J.; Tan, W.; Gu, J.G. TRPM8 mechanism of cold allodynia after chronic nerve injury. J. Neurosci. 2007, 27, 13680–13690.[CrossRef] [PubMed]
29. Frederick, J.; Buck, M.E.; Matson, D.J.; Cortright, D.N. Increased TRPA1, TRPM8, and TRPV2 expression in dorsal root ganglia by nerve injury. Biochem. Biophys. Res. Commun. 2007, 358, 1058–1064.[CrossRef] [PubMed]
30. Berry, S.H.; Elliott, M.N.; Suttorp, M.; Bogart, L.M.; Stoto, M.A.; Eggers, P.; Nyberg, L.; Clemens, J.Q. Prevalence of symptoms of bladder pain syndrome/interstitial cystitis among adult females in the United States. J. Urol. 2011, 186, 540–544.[CrossRef] [PubMed]
31. Lashinger, E.S.; Steiginga, M.S.; Hieble, J.P.; Leon, L.A.; Gardner, S.D.; Nagilla, R.; Davenport, E.A.; Hoffman, B.E.; Laping, N.J.; Su, X. AMTB, a TRPM8 channel blocker: Evidence in rats for activity in overactive bladder and painful bladder syndrome. Am. J. Physiol. Renal Physiol. 2008, 295, F803–F810.[CrossRef] [PubMed]
32. Winchester, W.J.; Gore, K.; Glatt, S.; Petit, W.; Gardiner, J.C.; Conlon, K.; Postlethwaite, M.; Saintot, P.P.; Roberts, S.; Gosset, J.R. et al. Inhibition of TRPM8 channels reduces pain in the cold pressor test in humans. J. Pharm. Exp. Ther. 2014, 351, 259–269.[CrossRef] [PubMed]
33. Hayashi, T.; Kondo, T.; Ishimatsu, M.; Yamada, S.; Nakamura, K.; Matsuoka, K.; Akasu, T. Expression of the TRPM8-immunoreactivity in dorsal root ganglion neurons innervating the rat urinary bladder. J. Neurosci. Res. 2009, 65, 245–251.[CrossRef] [PubMed]
34. Mukerji, G.; Yiangou, Y.; Corcoran, S.L.; Selmer, I.S.; Smith, G.D.; Benham, C.D.; Bountra, C.; Agarwal, S.K.; Anand, P. Cool and menthol receptor TRPM8 in human urinary bladder disorders and clinical correlations. BMC Urol. 2006, 6, 6.[CrossRef] [PubMed]
35. Kobayashi, H.; Yoshiyama, M.; Zakoji, H.; Takeda, M.; Araki, I. Sex differences in the expression profile of acid-sensing ion channels in the mouse urinary bladder: A possible involvement in irritative bladder symptoms. BJU Int. 2009, 104, 1746–1751.[CrossRef] [PubMed]
36. Ito, H.; Aizawa, N.; Sugiyama, R.; Watanabe, S.; Takahashi, N.; Tajimi, M.; Fukuhara, H.; Homma, Y.; Kubota, Y.; Andersson, K.E. et al. Functional role of the transient receptor potential melastatin 8 (TRPM8) ion channel in the urinary bladder assessed by conscious cystometry and ex vivo measurements of single-unit mechanosensitive bladder afferent activities in the rat. BJU Int. 2016, 117, 484–494.[CrossRef] [PubMed]
37. Dussor, G.; Cao, Y.Q. TRPM8 and Migraine. Headache 2016, 56, 1406–1417.[CrossRef] [PubMed]
38. Chasman, D.I.; Anttila, V.; Buring, J.E.; Ridker, P.M.; Schurks, M.; Kurth, T. Selectivity in genetic association with sub-classified migraine in women. PLoS Genet. 2014, 10, e1004366.[CrossRef] [PubMed]
39. Chasman, D.I.; Schurks, M.; Anttila, V.; de Vries, B.; Schminke, U.; Launer, L.J.; Terwindt, G.M.; van den Maagdenberg, A.M.; Fendrich, K.; Volzke, H. et al. Genome-wide association study reveals three susceptibility loci for common migraine in the general population. Nat. Genet. 2011, 43, 695–698.[CrossRef] [PubMed]
40. Freilinger, T.; Anttila, V.; de Vries, B.; Malik, R.; Kallela, M.; Terwindt, G.M.; Pozo-Rosich, P.; Winsvold, B.; Nyholt, D.R.; van Oosterhout, W.P. et al. Genome-wide association analysis identifies susceptibility loci for migraine without aura. Nat. Genet. 2012, 44, 777–782.[CrossRef] [PubMed]
41. Esserlind, A.L.; Christensen, A.F.; Le, H.; Kirchmann, M.; Hauge, A.W.; Toyserkani, N.M.; Hansen, T.; Grarup, N.; Werge, T.; Steinberg, S. et al. Replication and meta-analysis of common variants identifies a genome-wide significant locus in migraine. Eur. J. Neurol. 2013, 20, 765–772.[CrossRef] [PubMed]
42. Zhao, H.; Eising, E.; de Vries, B.; Vijfhuizen, L.S.; International Headache Genetics Consortium; Anttila, V.; Winsvold, B.S.; Kurth, T.; Stefansson, H.; Kallela, M. et al. Gene-based pleiotropy across migraine with aura and migraine without aura patient groups. Cephalalgia 2016, 36, 648–657.[CrossRef] [PubMed]
43. Carreno, O.; Corominas, R.; Fernandez-Morales, J.; Camina, M.; Sobrido, M.J.; Fernandez-Fernandez, J.M.; Pozo-Rosich, P.; Cormand, B.; Macaya, A. SNP variants within the vanilloid TRPV1 and TRPV3 receptor genes are associated with migraine in the Spanish population. Am. J. Med. Genet. B Neuropsychiatr. Genet. 2012, 159B, 94–103.[CrossRef] [PubMed]
44. An, X.K.; Ma, Q.L.; Lin, Q.; Zhang, X.R.; Lu, C.X.; Qu, H.L. PRDM16 rs2651899 variant is a risk factor for Chinese common migraine patients. Headache 2013, 53, 1595–1601.[CrossRef] [PubMed]
45. Ghosh, J.; Pradhan, S.; Mittal, B. Genome-wide-associated variants in migraine susceptibility: A replication study from North India. Headache 2013, 53, 1583–1594.[CrossRef] [PubMed]
46. Sintas, C.; Fernandez-Morales, J.; Vila-Pueyo, M.; Narberhaus, B.; Arenas, C.; Pozo-Rosich, P.; Macaya, A.; Cormand, B. Replication study of previous migraine genome-wide association study findings in a Spanish sample of migraine with aura. Cephalalgia 2015, 35, 776–782.[CrossRef] [PubMed]
47. Fan, X.; Wang, J.; Fan, W.; Chen, L.; Gui, B.; Tan, G.; Zhou, J. Replication of migraine GWAS susceptibility loci in Chinese Han population. Headache 2014, 54, 709–715.[CrossRef] [PubMed]
48. Burgos-Vega, C.C.; Ahn, D.D.; Bischoff, C.; Wang, W.; Horne, D.; Wang, J.; Gavva, N.; Dussor, G. Meningeal transient receptor potential channel M8 activation causes cutaneous facial and hindpaw allodynia in a preclinical rodent model of headache. Cephalalgia 2016, 36, 185–193.[CrossRef] [PubMed]
49. Huang, D.; Li, S.; Dhaka, A.; Story, G.M.; Cao, Y.Q. Expression of the transient receptor potential channels TRPV1, TRPA1 and TRPM8 in mouse trigeminal primary afferent neurons innervating the dura. Mol. Pain 2012, 8, 66.[CrossRef] [PubMed]
50. Dussor, G.; Yan, J.; Xie, J.Y.; Ossipov, M.H.; Dodick, D.W.; Porreca, F. Targeting TRP channels for novel migraine therapeutics. ACS Chem. Neurosci. 2014, 5, 1085–1096.[CrossRef] [PubMed]
51. Lehto, S.G.; Weyer, A.D.; Zhang, M.; Youngblood, B.D.; Wang, J.; Wang, W.; Kerstein, P.C.; Davis, C.; Wild, K.D.; Stucky, C.L. et al. AMG2850, a potent and selective TRPM8 antagonist, is not effective in rat models of inflammatory mechanical hypersensitivity and neuropathic tactile allodynia. Naunyn Schmiedebergs Arch. Pharmacol. 2015, 388, 465–476.[CrossRef] [PubMed]
52. Gaudioso, C.; Hao, J.; Martin-Eauclaire, M.F.; Gabriac, M.; Delmas, P. Menthol pain relief through cumulative inactivation of voltage-gated sodium channels. Pain 2012, 153, 473–484.[CrossRef] [PubMed]
53. Namer, B.; Seifert, F.; Handwerker, H.O.; Maihofner, C. TRPA1 and TRPM8 activation in humans: Effects of cinnamaldehyde and menthol. Neuroreport 2005, 16, 955–959.[CrossRef] [PubMed]
54. Wasner, G.; Schattschneider, J.; Binder, A.; Baron, R. Topical menthol–a human model for cold pain by activation and sensitization of C nociceptors. Brain 2004, 127, 1159–1171.[CrossRef] [PubMed]
55. Hatem, S.; Attal, N.; Willer, J.C.; Bouhassira, D. Psychophysical study of the effects of topical application of menthol in healthy volunteers. Pain 2006, 122, 190–196.[CrossRef] [PubMed]
56. DeFalco, J.; Duncton, M.A.; Emerling, D.: TRPM8 biology and medicinal chemistry. Curr. Top. Med. Chem. 2011, 11, 2237–2252.[CrossRef] [PubMed]
57. Eid, S.R.: Therapeutic targeting of TRP channels–the TR(i)P to pain relief. Curr. Top. Med. Chem. 2011, 11, 2118–2130.[CrossRef] [PubMed]
58. Premkumar, L.S.; Abooj, M. TRP channels and analgesia. Life Sci. 2013, 92, 415–424.[CrossRef] [PubMed]
59. Feketa, V.V.; Zhang, Y.; Cao, Z.; Balasubramanian, A.; Flores, C.M.; Player, M.R.; Marrelli, S.P. Transient receptor potential melastatin 8 channel inhibition potentiates the hypothermic response to transient receptor potential vanilloid 1 activation in the conscious mouse. Crit. Care Med. 2014, 42, e355–e363.[CrossRef] [PubMed]
60. Zhu, B.; Xia, M.; Xu, X.; Ludovici, D.W.; Tennakoon, M.; Youngman, M.A.; Matthews, J.M.; Dax, S.L.; Colburn, R.W.; Qin, N. et al. Arylglycine derivatives as potent transient receptor potential melastatin 8 (TRPM8) antagonists. Bioorg. Med. Chem. Lett. 2013, 23, 2234–2237.[CrossRef] [PubMed]
61. Matthews, J.M.; Qin, N.; Colburn, R.W.; Dax, S.L.; Hawkins, M.; McNally, J.J.; Reany, L.; Youngman, M.A.; Baker, J.; Hutchinson, T. et al. The design and synthesis of novel, phosphonate-containing transient receptor potential melastatin 8 (TRPM8) antagonists. Bioorg. Med. Chem. Lett. 2012, 22, 2922–2926.[CrossRef] [PubMed]
62. Calvo, R.R.; Meegalla, S.K.; Parks, D.J.; Parsons, W.H.; Ballentine, S.K.; Lubin, M.L.; Schneider, C.; Colburn, R.W.; Flores, C.M.; Player, M.R. Discovery of vinylcycloalkyl-substituted benzimidazole TRPM8 antagonists effective in the treatment of cold allodynia. Bioorg. Med. Chem. Lett. 2012, 22, 1903–1907.[CrossRef] [PubMed]
63. Parks, D.J.; Parsons, W.H.; Colburn, R.W.; Meegalla, S.K.; Ballentine, S.K.; Illig, C.R.; Qin, N.; Liu, Y.; Hutchinson, T.L.; Lubin, M.L. et al. Design and optimization of benzimidazole-containing transient receptor potential melastatin 8 (TRPM8) antagonists. J. Med. Chem. 2011, 54, 233–247.[CrossRef] [PubMed]
64. Chaudhari, S.S.; Kadam, A.B.; Khairatkar-Joshi, N.; Mukhopadhyay, I.; Karnik, P.V.; Raghuram, A.; Rao, S.S.; Vaiyapuri, T.S.; Wale, D.P.; Bhosale, V.M. et al. Synthesis and pharmacological evaluation of novel N-aryl-3,4-dihydro-10H-spiro[chromene-2,40-piperidine]-10-carboxamides as TRPM8 antagonists. Bioorg. Med. Chem. Lett. 2013, 21, 6542–6553.[CrossRef] [PubMed]
65. Ohmi, M.; Shishido, Y.; Inoue, T.; Ando, K.; Fujiuchi, A.; Yamada, A.; Watanabe, S.; Kawamura, K.: Identification of a novel 2-pyridyl-benzensulfonamide derivative, RQ-00203078, as a selective and orally active TRPM8 antagonist. Bioorg. Med. Chem. Lett. 2014, 24, 5364–5368.[CrossRef] [PubMed]
66. Tamayo, N.A.; Bo, Y.; Gore, V.; Ma, V.; Nishimura, N.; Tang, P.; Deng, H.; Klionsky, L.; Lehto, S.G.; Wang, W. et al. Fused piperidines as a novel class of potent and orally available transient receptor potential melastatin type 8 (TRPM8) antagonists. J. Med. Chem. 2012, 55, 1593–1611.[CrossRef] [PubMed]
67. Horne, D.B.; Tamayo, N.A.; Bartberger, M.D.; Bo, Y.; Clarine, J.; Davis, C.D.; Gore, V.K.; Kaller, M.R.; Lehto, S.G.; Ma, V.V. et al. Optimization of Potency and Pharmacokinetic Properties of Tetrahydroisoquinoline Transient Receptor Potential Melastatin 8 (TRPM8) Antagonists. J. Med. Chem. 2014, 57, 2989–3004.[CrossRef] [PubMed]
68. Andrews, M.D.; Af Forselles, K.; Beaumont, K.; Galan, S.R.; Glossop, P.A.; Grenie, M.; Jessiman, A.; Kenyon, A.S.; Lunn, G.; Maw, G. et al. Discovery of a Selective TRPM8 Antagonist with Clinical Efficacy in Cold-Related Pain. ACS Med. Chem. Lett. 2015, 6, 419–424.[CrossRef] [PubMed]
69. Almeida, M.C.; Hew-Butler, T.; Soriano, R.N.; Rao, S.; Wang, W.; Wang, J.; Tamayo, N.; Oliveira, D.L.; Nucci, T.B.; Aryal, P. et al. Pharmacological blockade of the cold receptor TRPM8 attenuates autonomic and behavioral cold defenses and decreases deep body temperature. J. Neurosci. 2012, 32, 2086–2099.[CrossRef] [PubMed]
70. Miller, S.; Rao, S.; Wang, W.; Liu, H.; Wang, J.; Gavva, N.R. Antibodies to the extracellular pore loop of TRPM8 act as antagonists of channel activation. PLoS ONE 2014, 9, e107151.[CrossRef] [PubMed]
71. Gavva, N.R.; Davis, C.; Lehto, S.G.; Rao, S.; Wang, W.; Zhu, D.X. Transient receptor potential melastatin 8 (TRPM8) channels are involved in body temperature regulation. Mol. Pain 2012, 8, 36.[CrossRef] [PubMed]
72. Grisold, W.; Cavaletti, G.; Windebank, A.J.: Peripheral neuropathies from chemotherapeutics and targeted agents: Diagnosis, treatment, and prevention. Neuro-Oncology 2012.[CrossRef] [PubMed]
73. Windebank, A.J.; Grisold, W. Chemotherapy-induced neuropathy. J. Peripher. Nerv. Syst. 2008, 13, 27–46.[CrossRef] [PubMed]
74. Pachman, D.R.; Barton, D.L.; Watson, J.C.; Loprinzi, C.L. Chemotherapy-induced peripheral neuropathy: Prevention and treatment. Clin. Pharmacol. Ther. 2011, 90, 377–387.[CrossRef] [PubMed]
75. Basso, L.; Altier, C. Transient Receptor Potential Channels in neuropathic pain. Curr. Opin. Pharmacol. 2016, 32, 9–15.[CrossRef] [PubMed]
76. Clinical Trials.gov. Available online: https://clinicaltrials.gov/ (accessed on 24 March 2017).